grant
NIH StrokeNet National Clinical Coordinating Center (NCC)
Organization UNIVERSITY OF CINCINNATILocation CINCINNATI, UNITED STATESPosted 30 Sept 2013Deadline 30 Nov 2028
NIHUS FederalResearch GrantFY2026AcuteAddressAdvisory CommitteesAdvocacyAgeAgreementAncillary StudyApoplexyApplications GrantsAreaBiological MarkersBrain Vascular AccidentBrain Vascular DisordersCOVID crisisCOVID epidemicCOVID infected patientCOVID pandemicCOVID patientCOVID positive patientCOVID-19 crisisCOVID-19 epidemicCOVID-19 eraCOVID-19 global health crisisCOVID-19 global pandemicCOVID-19 health crisisCOVID-19 infected patientCOVID-19 infectionCOVID-19 pandemicCOVID-19 patientCOVID-19 periodCOVID-19 positive patientCOVID-19 public health crisisCOVID-19 virus infectionCOVID-19 yearsCOVID19 infectionCOVID19 patientCOVID19 positive patientCareer Development AwardsCareer Development Awards and ProgramsCareer Development Programs K-SeriesCaringCause of DeathCerebral StrokeCerebrovascular ApoplexyCerebrovascular DiseaseCerebrovascular DisordersCerebrovascular StrokeClinicalClinical InvestigatorClinical ResearchClinical StudyClinical TrialsCollaborationsCommunitiesConceptionsContinuance of educationContinuing EducationContracting OpportunitiesContractsCountryDedicationsDevicesDrugsEducationEducation and TrainingEducational aspectsElderlyEnrollmentEnsureEthnic OriginEthnicityFeasibility StudiesFeedbackFundingGenderGrantGrant ProposalsHospitalsIRBIRBsImageIncidenceInstitutional Review BoardsInternationalIntracranial Vascular DiseasesIntracranial Vascular DisordersInvestigatorsK-AwardsK-Series Research Career ProgramsLeadershipMedical RehabilitationMedicationMethodologyMinority RecruitmentMulti-Institutional Clinical TrialMulti-center clinical trialMulti-site clinical trialMulticenter clinical trialMultisite clinical trialNINDSNational Institute of Neurological Diseases and StrokeNational Institute of Neurological Disorders and StrokeNational Institutes of HealthParticipantPatient RepresentativePatientsPediatricsPharmaceutical PreparationsPharmaciesPharmacy facilityPhasePopulationPreventionProcessProfessional EducationRaceRacesRecoveryRehabilitationRehabilitation therapyResearchResearch Career ProgramResearch PersonnelResearch ResourcesResearchersResourcesSARS-CoV-2 epidemicSARS-CoV-2 global health crisisSARS-CoV-2 global pandemicSARS-CoV-2 infected patientSARS-CoV-2 infectionSARS-CoV-2 pandemicSARS-CoV-2 patientSARS-CoV-2 positive patientSARS-CoV2 infectionSARS-coronavirus-2 epidemicSARS-coronavirus-2 pandemicScienceSeriesSevere Acute Respiratory Syndrome CoV 2 epidemicSevere Acute Respiratory Syndrome CoV 2 pandemicSevere acute respiratory syndrome coronavirus 2 epidemicSevere acute respiratory syndrome coronavirus 2 infectionSevere acute respiratory syndrome coronavirus 2 pandemicSiteStandardizationStrokeStrokeNet trialsTask ForcesTestingTrainingTraining and EducationUnited States National Institutes of HealthUniversitiesWorkWorking strokeadvanced ageadvisory teamaged groupaged groupsaged individualaged individualsaged peopleaged personaged personsaged populationaged populationsagesaging populationbasebasesbio-markersbiologic markerbiomarkerbiomarker validationbrain attackbrain vascular diseasebrain vascular dysfunctioncareer developmentcerebral vascular accidentcerebral vascular diseasecerebral vascular dysfunctioncerebrovascular accidentcerebrovascular dysfunctionclinical practiceclinical research siteclinical sitecommunity partnerscommunity-based partnersconferenceconventioncoronavirus disease 2019 crisiscoronavirus disease 2019 epidemiccoronavirus disease 2019 global health crisiscoronavirus disease 2019 global pandemiccoronavirus disease 2019 health crisiscoronavirus disease 2019 infected patientcoronavirus disease 2019 infectioncoronavirus disease 2019 pandemiccoronavirus disease 2019 patientcoronavirus disease 2019 positive patientcoronavirus disease 2019 public health crisiscoronavirus disease crisiscoronavirus disease epidemiccoronavirus disease infected patientcoronavirus disease pandemiccoronavirus disease patientcoronavirus disease positive patientcoronavirus disease-19 global pandemiccoronavirus disease-19 pandemiccoronavirus disease-19 patientcoronavirus patientdesigndesigningdisabilitydrug/agente-ConsenteConsentelectronic consentenrollexperiencegeriatricimagingimprovedindustrial partnershipindustry partnerindustry partnershipinfected with COVID-19infected with COVID19infected with SARS-CoV-2infected with SARS-CoV2infected with coronavirus disease 2019infected with severe acute respiratory syndrome coronavirus 2infection with SARS-CoV-2innovateinnovationinnovativeintracranial vascular dysfunctionmarker validationmembermulti-site trialmultidisciplinarymultisite trialnew approachesnext generationnovel approachesnovel strategiesnovel strategyparticipant retentionpatient infected with COVIDpatient infected with COVID-19patient infected with SARS-CoV-2patient infected with coronavirus diseasepatient infected with coronavirus disease 2019patient infected with severe acute respiratory syndrome coronavirus 2patient populationpatient with COVIDpatient with COVID-19patient with COVID19patient with SARS-CoV-2patient with coronavirus diseasepatient with coronavirus disease 2019patient with severe acute respiratory distress syndrome coronavirus 2paymentpopulation agingpre-clinicalpreclinicalpreventpreventingracialracial backgroundracial originrecruitrecruiting minoritiesrehab therapyrehabilitation after strokerehabilitativerehabilitative therapysenior citizensevere acute respiratory syndrome coronavirus 2 global health crisissevere acute respiratory syndrome coronavirus 2 global pandemicsevere acute respiratory syndrome coronavirus 2 infected patientsevere acute respiratory syndrome coronavirus 2 patientsevere acute respiratory syndrome coronavirus 2 positive patientsexstroke rehabstroke rehabilitationstroke trialsstrokedstrokessummitsymposiasymposiumtelerehabtelerehabilitationtelestrokethrombotictimelinetrial designvalidation studieswork groupworking group
Description preview
Stroke is the second leading cause of death worldwide with an even greater burden of major disability. It occurs at all ages with the greatest incidence in the elderly. The number of strokes is expected to rise in the US and worldwide as the population ages. In 2013, NINDS established NIH StrokeNet to harness the leadership and experience of the…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click